Welcome to LookChem.com Sign In|Join Free
  • or
(R)-dimethyl 3,3'-(1-phenylethylazanediyl)dipropanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

215233-95-7

Post Buying Request

215233-95-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

215233-95-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 215233-95-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,5,2,3 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 215233-95:
(8*2)+(7*1)+(6*5)+(5*2)+(4*3)+(3*3)+(2*9)+(1*5)=107
107 % 10 = 7
So 215233-95-7 is a valid CAS Registry Number.

215233-95-7Relevant academic research and scientific papers

Synthesis and antihistamine evaluations of novel loratadine analogues

Wang, Yue,Wang, Juan,Lin, Yan,Si-Ma, Li-Feng,Wang, Dong-Hua,Chen, Li-Gong,Liu, Deng-Ke

, p. 4454 - 4456 (2011)

A series of loratadine analogues containing hydroxyl group and chiral center were synthesized. The effect of the synthesized compounds on the histamine-induced contractions of guinea-pig ileum muscles was studied. In addition, the in vivo asthma-relieving effect of the analogues in the histamine induced asthmatic reaction in guinea-pigs was determined. Most of the compounds exhibited definite H1 antihistamine activity. The S-enantiomers, compounds 2, 4 and 8, are more potent than the R-enantiomers, compounds 1, 3 and 7. Compound 6 was the most active one among the eight synthesized compounds.

Novel symmetrical trans-bis-Schiff bases of N-substituted-4- piperidones: Synthesis, characterization, and preliminary antileukemia activity mensurations

Sun, Chuan-Wen,Wang, Hai-Feng,Zhu, Jun,Yang, Ding-Rong,Xing, Jiahua,Jin, Jia

, p. 1374 - 1380 (2014/01/06)

A series of novel symmetrical trans-bis-Schiff bases (11a, 11b, 11c, 11d, 11e, 11f, 11g, 11h, 11i, 11j, 11k, 11l, 11m) were designed and prepared as novel anticancer analogues, with the trans-configuration confirmed by X-ray diffraction. Preliminary inhibitory effects of these compounds on CML K562 cell growth were investigated, and the potential analogue 11e showed an excellent anti-leukemia activity (IC50=6.35 μg/mL), which is higher than that of the clinical drug 5-fluorouracil (IC50=8.48 μg/mL). Complete assignments had been achieved for the title compounds by spectroscopic techniques, and their structure-activity relationships have been studied.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 215233-95-7